We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
---|---|---|---|---|---|
Advanced Oncotherapy Plc | LSE:AVO | London | Ordinary Share | GB00BD6SX109 | ORD 25P |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
0.00 | 0.00% | 1.925 | - | 0.00 | 01:00:00 |
Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
---|---|---|---|---|---|
Medical Laboratories | 0 | -29.49M | -0.0549 | -0.35 | 10.32M |
Date | Subject | Author | Discuss |
---|---|---|---|
09/2/2017 09:36 | Why are you here Iggy? Do you hold? If so then, given your views you'd be better off out. If not,really, why are you here? | freddythefish | |
09/2/2017 09:13 | daijavu - not at all. But the company needs businessmen not more quacks. | igbertsponk | |
09/2/2017 09:07 | Igbert. Do you regard all doctors as quacks? | daijavu | |
09/2/2017 07:30 | So now they appoint the quack who hadn't declared his holding to the Board. Guess he's done the crime now has to do the time! | igbertsponk | |
08/2/2017 19:29 | Interesting storyline developing on Emmerdale (Sara to get proton therapy) | daithedeath | |
08/2/2017 08:17 | Beggars belief that someone so close to the company can have 3.6% and no one knows about it! The corporate governance of this company stinks. All listed companies these days have registers of interests that are presented to every board meeting. And all directors and PDMRs have to get the Chairmans permission before dealing. And most companies actually track their large shareholders to make sure that large holdings are notified to them. Unforgivable incompetent negligence. | igbertsponk | |
08/2/2017 07:25 | So more unreported dealing (only 8 months late). Drip, drip. Must of bought Evans shares. Bet he regrets that given the SP! | waterloo01 | |
07/2/2017 12:05 | That would certainly be a huge blow, waterloo, even more significant than Sinophi. But I agree with your concerns. I also noticed that in their RNS advising the dates for the building work at Harley Street, there was no mention of estimated dates for installation of the machine, which I thought rather odd. | vatnabrekk | |
07/2/2017 10:37 | It strikes me that the next potential shoe to drop will be Circle health and De' Walden. Given the companies dislike of keeping holders informed in a timely manner, It wouldn't surprise if they have already question spending such a large summ converting Harley St for a machine that is as yet untested. Don't be too shocked if Harley Street drops AVO as the supplier. | waterloo01 | |
06/2/2017 14:49 | Exactly - if AVO were even near on track, Sinophi could have used the delay as a reason to demand a discount or more commission on future sales. They didn't.... | igbertsponk | |
06/2/2017 14:47 | Sadly, Karolina, I agree with you. | vatnabrekk | |
06/2/2017 13:32 | Whilst I never thought for one minute that AVO would get a penny out of Sinophi, I did think they had a fair chance of keeping what had already been paid. Clearly AVO had a very weak hand in these negotiations. If everything was on track with the development of LIGHT why have AVO got such a weak hand and why do Sinophi want to pull out of the whole deal and lose the ability to distribute to other hospitals when there is a working prototype, which if everything really is on track, is only a few months away? I presume the hospitals still want to offer proton therapy and therefore presume that Sinophi will be looking to source and supply alternative products which work and are available in the timescales the hospitals want. The big issue for AVO now is securing the finance they need to keep going. I very much doubt that they could finish testing and get a working prototype without a significant injection of cash. I can see a deeply discounted placing coming very soon. | sweet karolina | |
06/2/2017 09:09 | Agreed gerhart: decks cleared quickly, move on. This was always a punt and hopefully no one here has bet their house on it. | sea and sky | |
06/2/2017 09:03 | Well there isn't much good that can be said about it, than perhaps they are not going to get side-tracked emotion/expense-wise on pointless litigation. Hopefully hard lessons have been learned. They have been quick to clear the decks on this, and issued RNS recently about financing. So maybe clutching at straws, but are they clearing the decks to move forward and leave past weakness behind? We'll see.... | gerhart | |
06/2/2017 08:53 | I'm not aware of the in depth details of the PO, I don't remember AVO saying they woukd sue? They said they'd look into it sure. Saved us a bunch of legal money IMHO. | sea and sky | |
06/2/2017 08:50 | Sorry you see it way. I don't. | sea and sky | |
06/2/2017 08:40 | Sensibly????The other week Sinophi had no reason to cancel and AVO were going to sue for performance.And now they're giving them their money back?Amusing | igbertsponk | |
06/2/2017 08:22 | I see this as handled well. If you cant deliver on time customers have every right to cancel PO's. AVO and Sinophi have been 'sensible' by the look of things. Suing people only makes money for the lawyers. No doubt folk will bail a bit here but you either believe in the science or you don't. Sinophi are a business like any other. They have to look elsewhere. If as AVO say their tech is more flexible and cheaper then, once they have a working model who knows, Sinophi may well come back as they appear to have parted amicably. If only all business was conducted 'sensibly' eh? | sea and sky | |
06/2/2017 07:39 | Lol! Thought they were going to sue for trillions? Yet they've had to give a refund. Just shows how far behind timetable the company had slipped.Will be ages before it gets going. The loan providers have the company over a barrel and will dilute the existing equity down to buttons. Run! | igbertsponk | |
06/2/2017 07:18 | I'm sure it was amicable. They have paid back all the money. So much for pursing the UK company. Wrong people in charge here. | waterloo01 | |
02/2/2017 09:22 | TW may have contributed to the volatility in the price at times but the downward motion is all of the company's making. Blaming a trader/journalist like TW for the share price is tantamount to being in denial. That's a dangerous place in investing. As Vatnabrekk says, AVO can salvage something by getting on with their prototype and proving it works. Orders will then follow, assuming it is still ahead of the market then. For that reason, I still watch this share for a possible re-entry. | luminoso | |
30/1/2017 23:20 | I agree. This situation is not about TW, it's about AVO and the way that they have handled the situation that they found themselves in. There's no doubt that TW has got some of the issues right, but he has also got some of them wrong as well. He was wrong to say that the deposit was not shown in AVO's Accounts, because it was shown - not as Revenue, but correctly in the balance sheet. In my view he is also wrong to say that it's the end of the world because AVO have now lost all of their orders, so with no orders they cannot survive. At this stage of their development, I don't see that as being of any consequence, because if they produce a working, tested, verified prototype then I am sure that the potential customers will be queuing up. And finally, I'm not convinced that TW has had an enormous influence on the share price. A certain amount, perhaps, but I would hope that most investors would look at the issues he raises and investigate or research these to the best of their ability before making a decision, rather than just taking his word for it and jumping. | vatnabrekk | |
30/1/2017 13:17 | daijavu, I think you are crediting TW with far too much influence. The main factors driving the shareprice are the delays, the loss of sales, Evans selling his shares without notifying, NEDs walking and probably most importantly the high level of cash burn whilst needing to raise significant sums to have any hope of having a marketable product. I can't remember who thought the scope of the funding being increased was good news. I took that phase to mean needing more money for longer at higher interest rates with more security over the assets / seniority of the debt. They have also locked themselves into a bit of a conundrum. In order to deliver to other customers they need Harley St up and running first, but the funding for Harley St is dependant on them being able to convince the lender that they can make other sales. The Chinese Hospitals walking in the way they did has had the biggest impact on everything and I very much doubt any of those involved in that decision are even aware of TW. | sweet karolina | |
30/1/2017 09:46 | waterloo. I always respect your point of view and I'm sorry if you think I've spoken rubbish. I was simply telling it as I see it. I think that TW might well have a lot of influence on people. I've been in this game for a few years. I've made money and I've lost money. Looking back, I usually made money when I followed my own advice. I was in Cloudbuy when it was @UK, got out on the peak and made a fair bit. It was one of my early successes. I've made gains on a number of others as well. Whenever I listened to the advice of wiser heads I generally seemed to lose out by either not buying or by selling too early when things looked grim before they turned around. Consequently, I now tend to ignore the advice of others and rely on my own research and instincts. I may be wrong about TW and AVO but my instincts tell my I'm not. I am naturally concerned by the current financial situation and lack of orders but my current advice to myself is hold. When or if I really do feel I must sell, I will. | daijavu |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions